Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Early and Mid-term Results of Operation for Infective Endocarditis on Mitral Valve

감염성 승모판 심내막염의 중단기 수술 성적

  • Ahn, Byong-Hee (Dept. of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Chun, Joon-Kyung (Dept. of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Yu, Ung (Dept. of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Ryu, Sang-Wan (Dept. of Thoracic and Cardiovascular Surgery, Armed Forces Kwang-Ju Hospital) ;
  • Choi, Yong-Sun (Dept. of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Kim, Byong-Pyo (Dept. of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Hong, Sung-Bum (Dept. of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Bum, Min-Sun (Dept. of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Na, Kook-Ju (Dept. of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Park, Jong-Chun (Dept. of Cardiology, Chonam National University Medical School) ;
  • Kim, Sang-Hyung (Dept. of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School)
  • 안병희 (전남대학교 의과대학 흉부외과학교실) ;
  • 전준경 (전남대학교 의과대학 흉부외과학교실) ;
  • 유웅 (전남대학교 의과대학 흉부외과학교실) ;
  • 류상완 (국군광주병원 흉부외과) ;
  • 최용선 (전남대학교 의과대학 흉부외과학교실) ;
  • 김병표 (전남대학교 의과대학 흉부외과학교실) ;
  • 홍성범 (전남대학교 의과대학 흉부외과학교실) ;
  • 범민선 (전남대학교 의과대학 흉부외과학교실) ;
  • 나국주 (전남대학교 의과대학 흉부외과학교실) ;
  • 박종춘 (전남대학교 의과대학 심장내과학교실) ;
  • 김상형 (전남대학교 의과대학 흉부외과학교실)
  • Published : 2004.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Infective endocarditis shows higher operative morbidity and mortality rates than other cardiac diseases. The vast majority of studies on infective endocarditis have been made on aortic endocarditis, with little attention having been paid to infective endocarditis on the mitral valve. This study attempts to investigate the clinical aspects and operative results of infective endocarditis on the mitral valve. Meterial and Method: The subjects of this study consist of 23 patients who underwent operations for infective endocariditis on the mitral valve from June 1995 to May 2003. Among them, 2 patients suffered from prosthetic valvular endocarditis and the other 21 from native valvular endocarditis. The subjects were evenly distributed age-wise with an average age of 44.8$\pm$15.7 (11∼66) years. Emergency operations were performed on seventeen patients (73.9%) due to large vegetation or instable hemodynamic status. In preoperative examinations, twelve patients exhibited congestive heart failure, four patients renal failure, two patients spleen and renal infarction, and two patients temporary neurological defects, while one patient had a brain abscess. Based on the NYHA functional classification, seven patients were determined to be at Grade II, 9 patients at Grade III, and 6 patients at Grade IV. Vegetations were detected in 20 patients while mitral regurgitation was dominant in 19 patients with 4 patients showing up as mitral stenosis dominant on the preoperative echocardiogram. Blood cultures for causative organisms were performed on all patients, and positive results were obtained from ten patients, with five cases of Streptococcus viridance, two cases of methicillin-sensitive Staphylococcus aureus, and one case each of Corynebacteriurn, Haemophillis, and Gernella. Operations were decided according to the AA/AHA guidelines (1988). The mean follow-up period was 27.6 $\pm$23.3 (1 ∼ 97) months. Result: Mitral valve replacements were performed on 43 patients, with mechanical valves being used on 9 patients and tissue valves on the other 4. Several kinds of mitral valve repair or mitral valvuloplasty were carried out on the remaining 10 patients. Associated procedures included six aortic valve replacements, two tricuspid annuloplasty, one modified Maze operation, and one direct closure of a ventricular septal defect. Postoperative complications included two cases of bleeding and one case each of mediastinitis, low cardiac output syndrome, and pneumonia. There were no cases of early deaths, or death within 30 days following the operation. No patient died in the hospital or experienced valve related complications. One patient, however, underwent mitral valvuloplasty 3 months after the operation. Another patient died from intra-cranial hemorrhage in the 31st month after the operation. Therefore, the valve-related death rate was 4.3%, and the valve-related complication rate 8.6% on mid-term follow-up. 1, 3-, and 5-year valve- related event free rates were 90.8%, 79.5%, and 79.5%, respectively, while 1, follow-up. 1, 3-, and 5-year valve- related event free rates were 90.8%, 79.5%, and 79.5%, respectively, while 1, 3-, and 5-year survival rates were 100%, 88.8%, and 88.8%, respectively. Conclusion: The findings suggest that a complete removal of infected tissues is essential in the operative treatment of infectious endocarditis of the mitral valve. It is also suggested that when infected tissues are completely removed, neither type of material nor method of operation has a significant effect on the operation result. The postoperative results also suggest the need for a close follow-up observation of the patients suspected of having brain damage, which is caused by preoperative blood contamination or emboli from vegetation, for a possible cerebral vascular injury such as mycotic aneurysm.

배경: 감염성 심내막염은 다른 심장질환에 비해 유병률과 사망률이 높고, 대부분의 임상연구가 대동맥판에 발생한 심내막염에 편중되어 있어, 승모판 심내막염에 대한 보고는 상대적으로 드문데 이에 대한 임상양상 및 수술 결과를 분석하여 보고하고자 한다. 대상 및 방법: 1995년 6월부터 2003년 5월까지 전남대학교병원에서 감염성 승모판 심내막염으로 단일 술자에 의해서 외과적 치료를 받았던 23 예을 대상으로 하였다. 2예는 인공판막 심내막염이었고 나머지 21예는 자가판막 심내막염이었다. 환자의 평균 연령은 44.8$\pm$15.7 (11∼66)세였고 연령분포에는 큰 차이가 없었다. 17예에서는 혈역학적 불안정이나 거대 우종으로 응급수술을 시행하였다. 수술 전 12예에서 울혈성 심부전, 4예에서 신부전, 2예에서 비장 및 신장경색, 2예에서 일시적 뇌손상, 1예에서 뇌농양 소견을 보였다. NYHA 기능 분류상 Grade II가 7예, Grade III가 9예, Grade IV가 6예이었다. 술 전 심초음파상 승모판 역류우세가 19예, 협착우세가 4예이었으며, 우종은 20예(86.9%)에서 관찰되었다. 혈액배양 검사상 10예(43.4%)에서 원인균이 동종되었는데 Streptococcus viridans 5예, methicillin sensitive Staphylococcus aureus 2예, 그리고 Corynebacterium, Haemophillis, Gernella 각각 1예씩 이었다. 수술 적응증은 ACC/AHA 지침에 근거하였으며, 평균 외래 추적관찰기간은 27.6$\pm$23.3 (1∼97)개월이었다. 결과: 13예에서 승모판치환술을 시행하였는데 9예에서 기계판막을 사용하였고 4예에서 조직판막을 사용하였다. 10예에서 다양한 수기의 승모판성형술을 시행하였다. 동반수기로는 6예에서 대동맥판 치환술, 2예에서 삼첨판 성형술, 1예에서 변형된 미로수술, 1예에서 심실중격결손 낙합술을 시행하였다. 술 후 합병증으로는 출혈에 의한 재수술 2예, 종격동염 1예, 저심박출증 1예, 페렴 1예가 있었다. 술 후 30일 이내의 조기사망이나 병원 내 사망 및 판막 연관성 합병증은 없었다. 1예의 환자가 수술 3개월 후 다시 판막성형술을 받았고, 술 전 우종 전색에 의한 뇌경색을 보인 1예의 환자가 술 후 31개월에 뇌출혈로 사망하여 만기 전 체판막 연관성 사망률은 4.3%, 판막연관성 합병증은 8.6%였다. 1, 3, 5년 valve-related event free rate는 90.8%, 79.5%, 79.5%이었고 1, 3, 5년 생존율은 100%, 88.8%, 88.8% 이었다. 결론: 승모판 심내막염의 외과적 치료 시에는 감염된 조직의 완전 절제가 중요하며, 감염된 조직을 완전히 제거하면 대체물이나 수술 기법상의 차이가 결과에 미치는 영향은 크지 않을 것으로 판단되고, 술 전에 감염이나 우종 전색에 의한 뇌손상이 의심되는 환자에서는 술 후 추적관찰 중에도 뇌혈관 손상 가능성에 대해 주의 깊게 관찰하여야 할 것으로 생각된다.

Keywords

References

  1. Circulation v.31 Treatment of acute bacterial endocarditis by valve excision and replacement Wallace,A.G.;Young,W.G.;Osterhour,S. https://doi.org/10.1161/01.CIR.31.3.450
  2. Ann Thorac Surg v.70 Immediate and Long-term results of valve replacement for native and prosthetic valve endocarditis Delay,D.;Pellerin,M.;Carrier,M.(et al.) https://doi.org/10.1016/S0003-4975(00)01887-7
  3. Ann Thorac Surg v.75 Stentless aortic valve as an alternative to homografts for valve replacement in active infective endocarditis complicated by ring abscess Siniawski,H.;Lehmkuhl,H.;Weng,Y.(et al.) https://doi.org/10.1016/S0003-4975(02)04555-1
  4. J Am Coll Cardiol v.32 ACC/AHA guidelines for the management of patients with valvular heart disease. A report from the American college of Cardiology/America Heart Association Task Force on Practice Guidelines Bonow,R.O.;Carbello,B.;de Leon A.C.(et al.) https://doi.org/10.1016/S0735-1097(98)00454-9
  5. Ann Thorac Surg v.62 Guidelines for reporting morbidity and mortality after cardiac valvular operations Edmunds,L.H.;Clark,R.E.;Cohn,L.H.(et al.) https://doi.org/10.1016/S0003-4975(96)00531-0
  6. Glenn's Thoracic and Cardiovascualr Surgery (6th ed.) Surgery for bacterial endocarditis Frater,R.W.;Baue,A.E.(ed.);Geha,A.S.(ed.);Laks,H.(ed.)
  7. Am J Med v.32 Sequelae of bacterial endocarditis Robins,M.J.;Ruedy,J. https://doi.org/10.1016/0002-9343(62)90038-4
  8. Eur Heart J v.16 no.suppl B Early infective endocarditis on prosthetic valves Chastre,J.;Trouillet,J.L. https://doi.org/10.1093/eurheartj/16.suppl_B.32
  9. Eur Heart J v.5 no.suppl C Surgery in infective endocarditis Witchitz,S.;Regnier,B.;Wolff,M.;Rouvieux,E.;Lasine,M.J. https://doi.org/10.1093/eurheartj/5.suppl_C.87
  10. J Thoarc Cardiovasc Surg v.71 Operative treatment for infective endocarditis Stison,E.B.;Griepp,R.B.;Vosti,K.(et al.)
  11. Ann Thorac Surg v.62 Long-term results of operation for paravalvular abscess D'Udekem,Y.;David,T.E.;Feindel,C.M.;Armstrong,S.;Sun,Z. https://doi.org/10.1016/0003-4975(96)00274-3
  12. Ann Thorac Surg v.71 Acute endocarditis treated with radical debriedment and implantation of mechanical or stented bioprosthetic devices Aagaard,J.;Anderson,P.V. https://doi.org/10.1016/S0003-4975(00)02334-1
  13. Korean J Thoarc Cardiovasc Surg v.35 Short-term results of early surgery for active infective endocarditis Sung,K.I.;Park,P.W.
  14. Infective Endocarditis of Heart Valves Right and Left side endocarditis: Cerebral emboli Ting,W.;Silverman,N.A.;Levisky,S.;Gabbay,S.(ed.);Bonchek,L.I.(ed.);Bortolitti,U.(ed.)
  15. Circulation v.70 no.suppl I Homograft aortic root replacement for complicated prosthetic endocarditis Donaldson,R.M.;Ross,D.N. https://doi.org/10.1161/01.CIR.70.2.178
  16. J Thoarc Cardiovasc Surg v.104 Aortic valve infection McGiffin,D.C.;Galbraith,A.J.;Lachlan,G.J.(et al.)
  17. Ann Thorac Surg v.74 Reoperative cryopreserved root and ascending aorta replacement for acute aortic prosthetic valve endocarditis Lytle,B.W.;Sabik,J.F.;Blackstone,E.H.;Svensson,L.G.;Pettersson,G.B.;Cosgrove,D.M. https://doi.org/10.1016/S0003-4975(02)04129-2
  18. J Thoarc Cardiovasc Surg v.113 Aortic valve replacement for active infectious endocarditis in 108 patients Hydock,D.;Barratt-Boyes,B.;Macedo,T.(et al.) https://doi.org/10.1016/S0022-5223(97)70325-8
  19. J Thoarc Cardiovasc Surg v.103 Mitralvalve repair for bacterial endocarditis Henderson,W.G.;Morris,A.S.;Rosenkranz,E.R.(et al.)
  20. Ann Thorac Surg v.49 Valve repair in acute endocarditis Dreyfus,G.;Serraf,A.;Jebara,V.A.(et al.) https://doi.org/10.1016/0003-4975(90)90007-S
  21. Ann Thorac Surg v.72 Partial mitral valve replacement for acute endocarditis Jones,J.M.;Sarsam,M.A. https://doi.org/10.1016/S0003-4975(00)02582-0
  22. Heart valve replacement and reconstruction Techniques in mitral valve reconstruction Dudran,C.M.
  23. Eur J Cardiothoracic Surg v.10 Surgical treatment of the aortic valve with paravalvular abscess: consideration justifying mechanical replacement device Bauermschmit,R.;Vahl,C.F.;Lange,R.;Jakob,H.;Hagl,S. https://doi.org/10.1016/S1010-7940(96)80334-4